Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: The Italian Named Patient Program

F. Maines; U. De Giorgi; G. Procopio; G. Facchini; L. Fratino; R. Sabbatini; D. Gasparro; U. Basso; C. Mosillo; E. Campadelli; F. Massari; T. Sava; S. Sirotova; C. Messina; S. Scagliarini; V. Conteduca; E. Verzoni; S. Rossetti; A. Veccia; S. Kinspergher; O. Caffo

doi:10.2217/fon-2018-0113

Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: The Italian Named Patient Program

F. Maines, U. De Giorgi, G. Procopio, G. Facchini, L. Fratino, R. Sabbatini, D. Gasparro, U. Basso, C. Mosillo, E. Campadelli, F. Massari, T. Sava, S. Sirotova, C. Messina, S. Scagliarini, V. Conteduca, E. Verzoni, S. Rossetti, A. Veccia, S. KinspergherO. Caffo

Research output: Contribution to journal › Article › peer-review

Original language	Undefined/Unknown
Pages (from-to)	2691-2699
Number of pages	9
Journal	Future Oncology
Volume	14
Issue number	26
DOIs	https://doi.org/10.2217/fon-2018-0113
Publication status	Published - 2018

Access to Document

10.2217/fon-2018-0113

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055609041&doi=10.2217%2ffon-2018-0113&partnerID=40&md5=9510caf47d4353d50d1a0f20b9d67e3c

Cite this

Maines, F., De Giorgi, U., Procopio, G., Facchini, G., Fratino, L., Sabbatini, R., Gasparro, D., Basso, U., Mosillo, C., Campadelli, E., Massari, F., Sava, T., Sirotova, S., Messina, C., Scagliarini, S., Conteduca, V., Verzoni, E., Rossetti, S., Veccia, A., ... Caffo, O. (2018). Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: The Italian Named Patient Program. Future Oncology, 14(26), 2691-2699. https://doi.org/10.2217/fon-2018-0113

Maines, F, De Giorgi, U , Procopio, G , Facchini, G , Fratino, L, Sabbatini, R, Gasparro, D, Basso, U, Mosillo, C, Campadelli, E, Massari, F, Sava, T, Sirotova, S, Messina, C, Scagliarini, S, Conteduca, V , Verzoni, E, Rossetti, S, Veccia, A, Kinspergher, S & Caffo, O 2018, 'Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: The Italian Named Patient Program', Future Oncology, vol. 14, no. 26, pp. 2691-2699. https://doi.org/10.2217/fon-2018-0113

@article{6b09abe595c342eabb66399c6c6247f4,

title = "Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: The Italian Named Patient Program",

author = "F. Maines and {De Giorgi}, U. and G. Procopio and G. Facchini and L. Fratino and R. Sabbatini and D. Gasparro and U. Basso and C. Mosillo and E. Campadelli and F. Massari and T. Sava and S. Sirotova and C. Messina and S. Scagliarini and V. Conteduca and E. Verzoni and S. Rossetti and A. Veccia and S. Kinspergher and O. Caffo",

note = "cited By 1",

year = "2018",

doi = "10.2217/fon-2018-0113",

language = "Non definita",

volume = "14",

pages = "2691--2699",

journal = "Future Oncology",

issn = "1479-6694",

publisher = "Future Medicine Ltd.",

number = "26",

}

TY - JOUR

T1 - Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: The Italian Named Patient Program

AU - Maines, F.

AU - De Giorgi, U.

AU - Procopio, G.

AU - Facchini, G.

AU - Fratino, L.

AU - Sabbatini, R.

AU - Gasparro, D.

AU - Basso, U.

AU - Mosillo, C.

AU - Campadelli, E.

AU - Massari, F.

AU - Sava, T.

AU - Sirotova, S.

AU - Messina, C.

AU - Scagliarini, S.

AU - Conteduca, V.

AU - Verzoni, E.

AU - Rossetti, S.

AU - Veccia, A.

AU - Kinspergher, S.

AU - Caffo, O.

N1 - cited By 1

PY - 2018

Y1 - 2018

U2 - 10.2217/fon-2018-0113

DO - 10.2217/fon-2018-0113

M3 - Articolo

VL - 14

SP - 2691

EP - 2699

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 26

ER -